Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1

Conditions

Multiple Myeloma 37Neoplasms, Plasma Cell 11Recurrence 6Lymphoma, Mantle-Cell 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Peripheral Nervous System Diseases 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Myeloid, Acute 2Immunoglobulin Light-chain Amyloidosis 2Glioblastoma 2Waldenstrom Macroglobulinemia 1Renal Insufficiency 1Rectal Neoplasms 1Pathologic Complete Response 1Paraproteinemias 1Pancreatic Neoplasms 1Ovarian Neoplasm Epithelial 1Neoplasms by Histologic Type 1Neoplasms 1Neoplasm, Residual 1Mesothelioma, Malignant 1Mesothelioma 1Lymphoma, T-Cell, Peripheral 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Liver Neoplasms 1Leukemia, Promyelocytic, Acute 1Leukemia, Plasma Cell 1Leukemia 1Hypoxia 1

Interventions

Trastuzumab 2toripalimab 1pyrotinib 1Vinblastine 1Transurethral Resection of Bladder 1Thalidomide 1TP protocol 1Sodium Chloride 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Positron Emission Tomography Computed Tomography 1Paclitaxel 1Neoadjuvant Therapy 1Metformin 1Magnetic Resonance Imaging 1Immunohistochemistry 1Esophagectomy 1Endoscopy 1Dynamic Contrast Enhanced Magnetic Resonance Imaging 1Diffusion Magnetic Resonance Imaging 1Dexamethasone 1Decitabine 1Cytarabine 1Cisplatin 1Chemoradiotherapy 1Cell-Free Nucleic Acids 1Carboplatin 1Bortezomib 1Blood Specimen Collection 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Pathologic Complete Response × Bortezomib × Clear all
NCT01134484 2012-07-20

VELCADE-Thalidomide-Dexamethasone (VTD) vs Thalidomide-Dexamethasone (TD) Incorporated Into Double Autotransplantation for Untreated Multiple Myeloma (MM)

IRCCS Azienda Ospedaliero-Universitaria di Bologna

Phase 3 Unknown
480 enrolled
Plasma cell

Pathologic Complete Response, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡